Gypenosides attenuate the development of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease

被引：0
|
作者：
Keon Sung Shin
Ting Ting Zhao
Keun Hong Park
Hyun Jin Park
Bang Yeon Hwang
Chong Kil Lee
Myung Koo Lee
机构：
[1] Chungbuk National University,College of Pharmacy and Research Center for Bioresource and Health
来源：
BMC Neuroscience | / 16卷
关键词：
6-Hydroxydopamine-lesioned rats; Dyskinesia; Body and locomotive AIMs scores; ∆FosB; ERK1/2; Adjuvant therapeutics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Gypenosides attenuate the development of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rat model of Parkinson's disease
    Shin, Keon Sung
    Zhao, Ting Ting
    Park, Keun Hong
    Park, Hyun Jin
    Hwang, Bang Yeon
    Lee, Chong Kil
    Lee, Myung Koo
    BMC NEUROSCIENCE, 2015, 16
  • [2] Behavioral and Cellular Modulation of L-DOPA-Induced Dyskinesia by β-Adrenoceptor Blockade in the 6-Hydroxydopamine-Lesioned Rat
    Lindenbach, David
    Ostock, Corinne Y.
    Jaunarajs, Karen L. Eskow
    Dupre, Kristin B.
    Barnum, Christopher J.
    Bhide, Nirmal
    Bishop, Christopher
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 337 (03): : 755 - 765
  • [3] Oral creatine supplementation attenuates L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats
    Valastro, Barbara
    Dekundy, Andrzej
    Danysz, Wojciech
    Quack, Guenter
    BEHAVIOURAL BRAIN RESEARCH, 2009, 197 (01) : 90 - 96
  • [4] EFFECT OF MEMANTINE ON L-DOPA-INDUCED DYSKINESIA IN THE 6-OHDA-LESIONED RAT MODEL OF PARKINSON'S DISEASE
    Tronci, E.
    Fidalgo, C.
    Zianni, E.
    Collu, M.
    Stancampiano, R.
    Morelli, M.
    Gardoni, F.
    Carta, M.
    NEUROSCIENCE, 2014, 265 : 245 - 252
  • [5] Hypertrophy of medial globus pallidus and substantia nigra reticulata in 6-hydroxydopamine-lesioned rats treated with L-DOPA: Implication for L-DOPA-induced dyskinesia in Parkinson's disease
    Tomiyama, M
    Mori, F
    Kimura, T
    Ichinohe, N
    Wakabayashi, K
    Matsunaga, M
    Baba, M
    NEUROPATHOLOGY, 2004, 24 (04) : 290 - 295
  • [6] L-Stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease
    Mo, Jiao
    Zhang, Hai
    Yu, Lei-Ping
    Sun, Pei-Hua
    Jin, Guo-Zhang
    Zhen, Xuechu
    NEUROBIOLOGY OF AGING, 2010, 31 (06) : 926 - 936
  • [7] Ceftriaxone Reduces L-Dopa-Induced Dyskinesia Severity in 6-hydroxydopamine Parkinson's Disease Model
    Chotibut, Tanya
    Meadows, Samantha
    Kasanga, Ella A.
    McInnis, Tamara
    Cantu, Mark A.
    Bishop, Christopher
    Salvatore, Michael F.
    MOVEMENT DISORDERS, 2017, 32 (11) : 1547 - 1556
  • [8] BN82451 attenuates L-dopa-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease
    Spinnewyn, Brigitte
    Mautino, Gisele
    Marin, Jean-Gregoire
    Rocher, Marie Noelle
    Grandoulier, Anne Sophie
    Ferrandis, Eric
    Auguet, Michel
    Chabrier, Pierre-Etienne
    NEUROPHARMACOLOGY, 2011, 60 (04) : 692 - 700
  • [9] Striatal overexpression of β-arrestin2 counteracts L-dopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson's disease rats
    Zhang, Zeng-Rui
    Zhang, Xing-Ru
    Luan, Xiao-Qian
    Wang, Xin-Shi
    Wang, Wen-Wen
    Wang, Xiao-Yi
    Shao, Bei
    Xie, Cheng-Long
    NEUROCHEMISTRY INTERNATIONAL, 2019, 131
  • [10] Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia
    Kobylecki, Christopher
    Crossman, Alan R.
    Ravenscroft, Paula
    EXPERIMENTAL NEUROLOGY, 2013, 247 : 476 - 484
12345